Advertisement
Advertisement
U.S. Markets close in 46 mins
Advertisement
Advertisement
Advertisement
Advertisement

Intra-Cellular Therapies, Inc. (ITCI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
40.30+0.05 (+0.12%)
As of 04:00PM EST. Market open.
Advertisement
Sign in to post a message.
  • M
    Matthew
    Moving up nicely today; glad I added more shares around $40. Approval in a couple weeks for Bipolar disorder and this could be a moonshot!
    Bullish
  • A
    Alan
    Morning All. Any thought out there on the approval date and if the stock has already baked positive news into the price. Or will we see a spike with positive results?
  • W
    WaGamba
    We should return to $47 range before 12/17
  • j
    julio d
    During the week ending 10/22, ITCI sold 1647 total Rx. It was an ATH in total, new, and refill Rx, and good for a roughly $100M annualized rate.
    Bullish
  • T
    TennisG
    What I don't like:
    Did I hear a 1 sec slip up on the CC during and Answer on Q&A?
    ITCI CONFERENCE CALL DID I HERE A SLIP UP - only 1 of 2 Pure MAJOR Depression STUDY passed the FDA test so far?? I'm double checking.
  • T
    TennisG
    "Nuttin Honey" and I woke up early on this cold near December morn.
  • g
    george
    what drug company would be a possible buyer for ITCI?
  • T
    TennisG
    I was wrong ....Thanks Chicago ....the data was on VRAYLAR.... not ITCI's
  • C
    Chicago J
    I thought the presentation was pretty darned good. There was a lot of information presented (not a lot of new stuff for those of us who track ITCI every day, but still!) and I liked how they broke up the event by product and pipeline with Q&A and even a panel of experts from outside ITCI.

    This was a focus on product and NOT an “Investor Day” presentation. No real talk that I picked up on related to cash, sales, etc. And that’s OK. In my wildest dreams, Wall Street would have picked up on all the successful product testing and announcements and the stock would go to $45. Am I surprised it basically didn’t move? No.

    Kudos to Dr. Sharon and the team for at least trying to get the good word out there about Caplyta and the pipeline. I’m usually very pointed in my criticism of Dr. Sharon, but I think today’s event was a good call. Hopefully it helps down the road. It’s long, but worth watching (I was multitasking but I definitely learned a few things).
  • T
    TennisG
    Well, I was wrong. We trickled up before your prediction (I thought the opposite). Yes, we will drop for a little while (48 hours only, I hope) But, after that, WHY would you expect another trickle up again? Is that expectation the same reason you have for a few day trickle up before this upcoming weekend, or next weekend? ( I know, I know..Powell, Politics, Virus Bull, Non Farm Payroll this week) but say all settles down. Friday at 11am.
  • W
    William
    All time high today. I think we double from here with good BP data.
  • C
    Clovus
    Breakout trade
    WATCH for breakout above 44.63
    Target: 48.46, 13%
    P/L ratio: 4.5 : 1 - Excellent
    Bullish
  • W
    William
    Nice growth in sales but still disappointing numbers imo considering the overall superiority of the drug. I still think management has done an extremely poor job promoting their product. We need Bipolar approval to move the stock. Disappointing to see net loss increase like it did too.
  • M
    MD
    Let’s get the action started, what’s your PPS after approval?
    Bullish
  • C
    Chicago J
    Looks like next Tuesday morning (11/9) will be our earnings call. I’m not expecting any big surprises with the numbers but it will be good to hear what the ITCI team has to say. I’m hoping the analysts ask some good questions.
  • M
    MD
    I hope FDA do not extend PDUFA for this critical expansion and patient needs (I own couple of other Biotechs and 2-3 of them PDUFA dates moved without ETA). Hoping FDA will keep up with the timeline.
    Bullish
  • m
    m
    RBC just now raised target from $44 to $48
  • C
    Clovus
    Bought back November $42 calls and replaced them with Dec $47 Five more dollars upside with out selling the stock. Very nice premium
    Covered Calls Sold ITCI December $47 covered calls for $4.80 a contract This means I have sold the stock at $51.80 if called. In December if the earnings are not out I might sell calls again for January at $52 strike
    Bullish
  • T
    TennisG
    I totally agree with the odds of approval. I will admit, I don't have the guts to add in the 40's here, because if this falls through (doubt it), the MDD will surely as well.
Advertisement
Advertisement